Invention Application
- Patent Title: Pharmaceutical Composition for Alzheimer's Disease
-
Application No.: US17613303Application Date: 2020-05-22
-
Publication No.: US20220226341A1Publication Date: 2022-07-21
- Inventor: Masatoshi Hagiwara , Masahiko Ajiro
- Applicant: Kyoto University
- Applicant Address: JP Kyoto-shi, Kyoto
- Assignee: Kyoto University
- Current Assignee: Kyoto University
- Current Assignee Address: JP Kyoto-shi, Kyoto
- Priority: JP2019-096908 20190523
- International Application: PCT/JP2020/020280 WO 20200522
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61K31/4545 ; A61K31/505 ; A61K9/00 ; A61P31/12
Abstract:
A novel pharmaceutical composition and method that enable the treatment, amelioration, prevention, and/or suppression of progression of Alzheimer's disease are provided.
Provided is a pharmaceutical composition for preventing, treating, suppressing the progression of, and/or ameliorating Alzheimer's disease, the pharmaceutical composition containing, as an active ingredient, a compound that is capable of suppressing the activation or growth of virus in the brain as one of factors that cause the onset or progression of Alzheimer's disease. Also provided is a method for preventing, treating, suppressing the progression of, and/or ameliorating Alzheimer's disease, the method including administering an effective amount of the compound to a subject.
Provided is a pharmaceutical composition for preventing, treating, suppressing the progression of, and/or ameliorating Alzheimer's disease, the pharmaceutical composition containing, as an active ingredient, a compound that is capable of suppressing the activation or growth of virus in the brain as one of factors that cause the onset or progression of Alzheimer's disease. Also provided is a method for preventing, treating, suppressing the progression of, and/or ameliorating Alzheimer's disease, the method including administering an effective amount of the compound to a subject.
Information query
